Financials Grand Brilliance Group Holdings Limited
Equities
8372
KYG4136R1020
Medical Equipment, Supplies & Distribution
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.094 HKD | -1.05% | -7.84% | -6.00% |
Valuation
Fiscal Period: März | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Capitalization 1 | 320 | 94.4 | 56.8 | 64 | 59.2 | 56.8 |
Enterprise Value (EV) 1 | 258.2 | 35.95 | -15.93 | -3.069 | 6.305 | -2.126 |
P/E ratio | -82.3 x | 14.3 x | 5.94 x | 8.14 x | 14.6 x | 7.51 x |
Yield | - | 1.06% | 6.16% | 5.63% | 4.05% | 5.63% |
Capitalization / Revenue | 5.96 x | 1.63 x | 0.84 x | 0.91 x | 0.82 x | 0.74 x |
EV / Revenue | 4.81 x | 0.62 x | -0.24 x | -0.04 x | 0.09 x | -0.03 x |
EV / EBITDA | 17.4 x | 4.15 x | -1.33 x | -0.38 x | 0.97 x | -0.26 x |
EV / FCF | 15.8 x | -7.19 x | -0.9 x | -1.6 x | -1.29 x | -0.2 x |
FCF Yield | 6.35% | -13.9% | -111% | -62.6% | -77.7% | -502% |
Price to Book | 4.29 x | 1.16 x | 0.64 x | 0.69 x | 0.63 x | 0.58 x |
Nbr of stocks (in thousands) | 800,000 | 800,000 | 800,000 | 800,000 | 800,000 | 800,000 |
Reference price 2 | 0.4000 | 0.1180 | 0.0710 | 0.0800 | 0.0740 | 0.0710 |
Announcement Date | 6/28/18 | 6/27/19 | 6/29/20 | 6/25/21 | 6/24/22 | 6/26/23 |
Income Statement Evolution (Annual data)
Fiscal Period: März | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net sales 1 | 53.7 | 58.04 | 67.23 | 70.24 | 71.98 | 76.7 |
EBITDA 1 | 14.84 | 8.665 | 11.99 | 8.181 | 6.533 | 8.222 |
EBIT 1 | 14.44 | 7.737 | 11.05 | 7.346 | 5.918 | 7.833 |
Operating Margin | 26.88% | 13.33% | 16.44% | 10.46% | 8.22% | 10.21% |
Earnings before Tax (EBT) 1 | -0.447 | 8.246 | 11.9 | 9.357 | 5.478 | 9.377 |
Net income 1 | -3.08 | 6.608 | 9.566 | 7.859 | 4.048 | 7.562 |
Net margin | -5.74% | 11.38% | 14.23% | 11.19% | 5.62% | 9.86% |
EPS 2 | -0.004862 | 0.008260 | 0.0120 | 0.009823 | 0.005060 | 0.009452 |
Free Cash Flow 1 | 16.39 | -5.003 | 17.68 | 1.92 | -4.901 | 10.68 |
FCF margin | 30.52% | -8.62% | 26.3% | 2.73% | -6.81% | 13.92% |
FCF Conversion (EBITDA) | 110.48% | - | 147.46% | 23.47% | - | 129.87% |
FCF Conversion (Net income) | - | - | 184.84% | 24.43% | - | 141.2% |
Dividend per Share | - | 0.001250 | 0.004375 | 0.004500 | 0.003000 | 0.004000 |
Announcement Date | 6/28/18 | 6/27/19 | 6/29/20 | 6/25/21 | 6/24/22 | 6/26/23 |
Balance Sheet Analysis
Fiscal Period: Maart | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net Debt 1 | - | - | - | - | - | - |
Net Cash position 1 | 61.8 | 58.4 | 72.7 | 67.1 | 52.9 | 58.9 |
Leverage (Debt/EBITDA) | - | - | - | - | - | - |
Free Cash Flow 1 | 16.4 | -5 | 17.7 | 1.92 | -4.9 | 10.7 |
ROE (net income / shareholders' equity) | -5.82% | 8.49% | 11.3% | 8.66% | 4.34% | 7.87% |
ROA (Net income/ Total Assets) | 14.6% | 5.38% | 7.05% | 4.23% | 3.33% | 4.34% |
Assets 1 | -21.16 | 122.9 | 135.8 | 185.6 | 121.7 | 174.2 |
Book Value Per Share 2 | 0.0900 | 0.1000 | 0.1100 | 0.1200 | 0.1200 | 0.1200 |
Cash Flow per Share 2 | 0.0800 | 0.0700 | 0.0900 | 0.0900 | 0.0700 | 0.0800 |
Capex 1 | 1.58 | 1.5 | 0.22 | 0.39 | 0.78 | 0.06 |
Capex / Sales | 2.95% | 2.59% | 0.32% | 0.55% | 1.09% | 0.08% |
Announcement Date | 6/28/18 | 6/27/19 | 6/29/20 | 6/25/21 | 6/24/22 | 6/26/23 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-6.00% | 9.61M | |
-3.41% | 9.4B | |
+30.20% | 1.92B | |
-3.90% | 1.39B | |
-7.38% | 1.18B | |
-18.42% | 856M | |
+0.48% | 470M | |
+3.62% | 437M | |
-48.10% | 360M | |
-24.72% | 333M |
- Stock Market
- Equities
- 8372 Stock
- Financials Grand Brilliance Group Holdings Limited